Determination, validation and standardization of a CMV DNA cut-off value in plasma for preemptive treatment of CMV infection in solid organ transplant recipients at lower risk for CMV infection
In: Journal of clinical virology, Jg. 56 (2013), Heft 1, S. 13-18
academicJournal
- print, 40 ref
Zugriff:
Background: Valganciclovir preemptive therapy guided by the viral load is the current strategy recommended for preventing CMV disease in CMV-seropositive Solid Organ Transplant Recipients (SOTR) at lower risk for developing CMV infection. However, universal viral load cut-off has not been established for initiating therapy. Objectives: Our goal was to define and validate a standardized cut-off determined in plasma by real-time PCR assay for initiating preemptive therapy in this population. Study design: A prospective cohort study of consecutive cases of CMV-seropositive SOTR was carried out. The cut-off value was determined in a derivation cohort and was validated in the validation cohort. Viral loads were determined using the Quant CMV LightCycler 2.0 real-time PCR System (Roche Applied Science) and results were standardized using the WHO International Standard for human CMV. Results: A viral load of 3983 IU/ml (2600 copies/ml) was established as the optimal cut-off for initiating preemptive therapy in a cohort of 141 patients with 982 tests and validated in a cohort of 252 recipients with a total of 2022 test. This cut-off had a 99.6% NPV indicating that the great majority of patients at lower risk will not develop CMV disease without specific antiviral therapy. The high sensitivity and specificity (89.9% and 88.9%, respectively) and the relatively small numbers of patients with CMV disease confirm that real-time PCR was optimal. Conclusions: We have established a cut-off viral load for starting preemptive therapy for CMV-seropositive SOT recipients. Our results emphasized the importance of a mandatory follow-up protocol for CMV-seropositive patients receiving preemptive treatment.
Titel: |
Determination, validation and standardization of a CMV DNA cut-off value in plasma for preemptive treatment of CMV infection in solid organ transplant recipients at lower risk for CMV infection
|
---|---|
Autor/in / Beteiligte Person: | MARTIN-GANDUL, C ; PEREZ-ROMERO, P ; SANCHEZ, M ; BERNAL, G ; SUAREZ, G ; SOBRINO, M ; MERINO, L ; CISNEROS, J. M ; CORDERO, E ; The Spanish Network for Research in Infectious Diseases (REIPI) |
Link: | |
Zeitschrift: | Journal of clinical virology, Jg. 56 (2013), Heft 1, S. 13-18 |
Veröffentlichung: | Amsterdam: Elsevier, 2013 |
Medientyp: | academicJournal |
Umfang: | print, 40 ref |
ISSN: | 1386-6532 (print) |
Schlagwort: |
|
Sonstiges: |
|